FDA official logo
GSRS logoPFDA official logo

LOTIVIBART

UNII:CV5TGS48YN
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:LOTIVIBART
GSRS Full Record:

  • 2851892-98-1
  • GSK 3810109A [WHO-DD]
  • GSK-3810109A
  • GSK3810109A
  • H-gamma1 heavy chain Homo sapiens (1-452) [VH (Homo sapiens IGHV1-2*02 (59.2%) -(IGHD) -IGHJ1*01 (72.7%) L123>T (117), T125>V (119), S128>A (122), CDR-IMGT [8.8.15] (26-33.51-58.97-111)) (1-122) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, CH3 D12, L14, G1v24 CH3 L107, S114 (CH1 K120 (219) (123-220), hinge 1-15 (221-235), CH2 (236-345), CH3 D12 (361), L14 (363), M107>L (433), N114>S (439) (346-450), CHS (451-452)) (123-452)], (225-210')-disulfide with L-kappa light chain Homo sapiens (1'-210') [V-KAPPA (Homo sapiens IGKV1-13*02 (69.6%) -IGKJ5*01 (70.0%) Q120>R (96'), T122>S (98'), E1125>H (101'), CDR-IMGT [6.3.5] (27'-32'.50'-52'.89'-93')) (1'-103') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (CKAPPA A45.1 (149'), V101 (187')) (104'-210')]; dimer (231-231'':234-234'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-DG44, glycoform alfa
  • Immunoglobulin G1 [433-leucine,439-serine], anti-(human immunodeficiency virus retroviral envelope glycoprotein gp120env CD4-binding site) (human clone VH3810109 γ1-chain), disulfide with human clone VH3810109 κ-chain, dimer
  • LOTIVIBART [USAN]
  • Lotivibart
  • N6LS
  • N6LS (RECOMBINANT HUMAN IMMUNOGLOBULIN G1 DIRECTED AGAINST THE CD4-BINDING SITE OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GLYCOPROTEIN 120)
  • VRC-HIVMAB091-00-AB
  • immunoglobulin G1-kappa, anti-[HIV-1 (human immunodeficiency virus type 1) gp120 envelope glycoprotein, CD4-binding site], Homo sapiens monoclonal antibody
  • lotivibart [INN]



UNII - CV5TGS48YN | UNII Search Service